CarMax (KMX): Earnings tomorrow can send this

Play Episode

12min

Proactive - Interviews for investors

hVIVO CEO on record FY24 revenue & EBITDA as expansion strategy pays off

hVIVO PLC chief executive Yamin ‘Mo’ Khan takes Proactive's Stephen Gunnion through the company’s record-breaking financial performance in 2024, operational milestones and strategic outlook. hVIVO reported a 12% rise in revenue to just under £63 million, with an EBITDA margin of 26%. Khan highlighted this as a record margin for the company. He noted that, even excluding a one-off facility fee, the margin remained strong at 23%. The company also ended the year with £44 million in cash. Khan explained: “This is all been based on a record number of inoculations… we ran nine challenge trials and our largest field study to date.” He emphasised the company’s transformation, with a move to a purpose-built 50-bed human challenge facility in Canary Wharf, improvements in operational efficiency, and a major expansion of lab and outpatient capacity. Looking ahead, hVIVO is targeting £73 million in revenue for 2025, of which £70 million is already contracted. The company is also launching new challenge models, including Omicron and hMPV, and pursuing its first phase 3 human trial. Khan also discussed recent acquisitions—CRS in Germany and Cryostore in the UK—and confirmed continued dividend payments, with 0.2p per share set for June. For more interviews like this, visit Proactive's YouTube channel. Don’t forget to like the video, subscribe, and turn on notifications for future updates. #hVIVO #ClinicalTrials #HumanChallengeTrials #BiotechNews #EBITDA #RevenueGrowth #Biopharma #DrugDevelopment #CRSAcquisition #CryoStore #VaccineTrials #AntiviralResearch #LifeSciences #PharmaPipeline

Proactive - Interviews for investors

Kodal Minerals nears completion at Bougouni Lithium project, prepares for exports

Kodal Minerals PLC (AIM:KOD) CEO Bernard Aylward takes Proactive's Stephen Gunnion through the company's latest update on its Bougouni lithium project in Mali, where construction is nearly complete and preparations for export are underway. Aylward shared that the optimisation and ramp-up phase of the processing plant has been going well, with over 11,000 tonnes of lithium concentrate already stockpiled and ready for export. "We've been making some adjustments as we go through this process and some improvements to the feed into the crusher... achieving a good product," he said. He noted that the company expects to reach nameplate capacity within the next couple of months, pending a final review and approval by the construction team. Kodal is also progressing steadily on the mining front, with a good run-of-mine (ROM) stockpile in place. The interview highlighted that the mining license transfer process is still ongoing, though Kodal has completed all compliance steps and is now awaiting sign-off from the Committee of Ministers and the President of Mali. Once this is finalised, the company will move forward with export permits and begin shipping product. Visit Proactive’s YouTube channel for more company updates. Don’t forget to like this video, subscribe, and turn on notifications to stay up to date. #KodalMinerals #Lithium #BougouniProject #MiningNews #BatteryMetals #MaliMining #ResourceDevelopment #LithiumProduction #MineralExploration #CriticalMinerals

Proactive - Interviews for investors

Ananda Pharma adds former GW Pharmaceuticals executive as strategic advisor, advances MRX1

Ananda Pharma Plc finance director Jeremy Sturgess-Smith talked with Proactive's Stephen Gunnion about the appointment of Chris Tovey as a strategic advisor. Tovey brings significant experience from his time as chief operating officer at GW Pharmaceuticals and later Jazz Pharmaceuticals. According to Sturgess-Smith: “He’s going to bring all that experience to Ananda,” helping guide the company through its regulatory path and corporate development. Sturgess-Smith also touched on Ananda securing ethics approval to begin its first human trial of MRX1, a key milestone for the company’s therapeutic pipeline. He noted this was the first ethics approval of its kind for any Ananda trial, with recruitment expected to begin shortly in Australia. “It’s very, very exciting to have that ethics approval in the bag,” he said. Looking ahead, the company also expects ethics approvals for studies into chemotherapy-induced peripheral neuropathy and endometriosis in the next six months. For more interviews and updates, visit Proactive's YouTube channel. Don’t forget to like this video, subscribe, and hit the notification bell to stay informed.** #AnandaPharma #MRX1Trial #ClinicalTrials #CannabinoidMedicine #BiotechNews #PharmaceuticalInnovation #EthicsApproval #GWPharma #DrugDevelopment #Epidiolex #HealthInnovation #ProactiveInvestors

Proactive - Interviews for investors

CleanTech Lithium appoints CEO with deep Chile experience and connections

CleanTech Lithium PLC (AIM:CTL, OTCQX:CTLHF) CEO Ignacio Mehech talked with Proactive's Stephen Gunnion about his priorities following his appointment as the company’s new chief executive. Mehech spoke about the company’s immediate focus and his own background in Chile’s mining sector. He described CleanTech as being at “a very special moment in time”, with several key developments underway including the CEOL (special lithium operation contract) negotiations with Chile’s Ministry of Mining, the delivery of a pre-feasibility study, and the search for a strategic partner. “We have gone all the way to produce lithium carbonate battery grade,” Mehech said, noting that the company has successfully piloted direct lithium extraction (DLE) technologies with its brine projects. Reflecting on his decade of experience in Chile’s mining industry, Mehech outlined his previous roles at Albemarle, including as country manager for Chile and VP of external affairs for Latin America. He stressed the importance of maintaining strong relationships with indigenous communities and government stakeholders in Chile, adding that CleanTech already has “a good relationship” that it must continue building on. He concluded by reinforcing the company’s short-term goals: “Finalise the negotiations on the CEOL with the Ministry of Mining, deliver the pre-feasibility study, and look for a strategic partner to develop this project.” For more insights, visit Proactive’s YouTube channel for additional videos. Don’t forget to like this video, subscribe, and enable notifications so you never miss an update. #CleanTechLithium #Lithium #LithiumExtraction #IgnacioMehech #Mining #MiningChile #BatteryMetals #LithiumBrine #StrategicPartnership #DLEtechnology #PreFeasibilityStudy #ProactiveInvestors

Followers	194
Posts	3544
Boards Moderated	1
Alias Born	09/30/2018

Volume:	2,270,752
Day Range:	63.63 - 64.77
Bid:
Ask:
Last Trade Time:	7:52:16 PM EDT
Total Trades:	33,893

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

KMX Detailed Quote

Recent KMX News

More KMX News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent KMX News

Go Ad-Free